References
1. Gulani, V.; Seiberlich, N., Quantitative MRI: Rationale and Challenges. In Advances in Magnetic Resonance Technology and Applications, Seiberlich, N.; Gulani, V.; Calamante, F.; Campbell-Washburn, A.; Doneva, M.; Hu, H. H.; Sourbron, S., Eds. Academic Press: 2020; Vol. 1, pp xxxvii-li.
2. Keenan, K. E.; Biller, J. R.; Delfino, J. G.; Boss, M. A.; Does, M. D.; Evelhoch, J. L.; Griswold, M. A.; Gunter, J. L.; Hinks, R. S.; Hoffman, S. W.; Kim, G.; Lattanzi, R.; Li, X.; Marinelli, L.; Metzger, G. J.; Mukherjee, P.; Nordstrom, R. J.; Peskin, A. P.; Perez, E.; Russek, S. E.; Sahiner, B.; Serkova, N.; Shukla-Dave, A.; Steckner, M.; Stupic, K. F.; Wilmes, L. J.; Wu, H. H.; Zhang, H.; Jackson, E. F.; Sullivan, D. C., Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. J Magn Reson Imaging 2019, 49 (7), e26-e39.
3. Cashmore, M. T.; McCann, A. J.; Wastling, S. J.; McGrath, C.; Thornton, J.; Hall, M. G., Clinical quantitative MRI and the need for metrology. British Journal of Radiology 2021, 94 (1120), 20201215.
4. Granziera, C.; Wuerfel, J.; Barkhof, F.; Calabrese, M.; De Stefano, N.; Enzinger, C.; Evangelou, N.; Filippi, M.; Geurts, J. J. G.; Reich, D. S.; Rocca, M. A.; Ropele, S.; Rovira, À.; Sati, P.; Toosy, A. T.; Vrenken, H.; Gandini Wheeler-Kingshott, C. A. M.; Kappos, L., Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain 2021, 144 (5), 1296-1311.
5. Carré, A.; Klausner, G.; Edjlali, M.; Lerousseau, M.; Briend-Diop, J.; Sun, R.; Ammari, S.; Reuzé, S.; Alvarez Andres, E.; Estienne, T.; Niyoteka, S.; Battistella, E.; Vakalopoulou, M.; Dhermain, F.; Paragios, N.; Deutsch, E.; Oppenheim, C.; Pallud, J.; Robert, C., Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics. Sci Rep 2020, 10 (1), 12340.
6. Xin, H.; Frey, E. C.; Links, J. M.; Gilland, K. L.; Segars, W. P.; Tsui, B. M. W., A mathematical observer study for the evaluation and optimization of compensation methods for myocardial SPECT using a phantom population that realistically models patient variability. IEEE Transactions on Nuclear Science 2004, 51 (1), 218-224.
7. Freed, M.; de Zwart, J. A.; Loud, J. T.; El Khouli, R. H.; Myers, K. J.; Greene, M. H.; Duyn, J. H.; Badano, A., An anthropomorphic phantom for quantitative evaluation of breast MRI. Med Phys 2011, 38 (2), 743-53.
8. Keenan, K. E.; Wilmes, L. J.; Aliu, S. O.; Newitt, D. C.; Jones, E. F.; Boss, M. A.; Stupic, K. F.; Russek, S. E.; Hylton, N. M., Design of a breast phantom for quantitative MRI. J Magn Reson Imaging 2016, 44 (3), 610-9.
9. Martaindale, S. R., Breast MR Imaging: Atlas of Anatomy, Physiology, Pathophysiology, and Breast Imaging Reporting and Data Systems Lexicon. Magn Reson Imaging Clin N Am 2018, 26 (2), 179-190.
10. Santucci, D.; Faiella, E.; Calabrese, A.; Beomonte Zobel, B.; Ascione, A.; Cerbelli, B.; Iannello, G.; Soda, P.; de Felice, C., On the Additional Information Provided by 3T-MRI ADC in Predicting Tumor Cellularity and Microscopic Behavior. Cancers (Basel) 2021, 13 (20).
11. McDonald, E. S.; Schopp, J. G.; Peacock, S.; DeMartini, W. B.; Rahbar, H.; Lehman, C. D.; Partridge, S. C., Diffusion-Weighted MRI: Association Between Patient Characteristics and Apparent Diffusion Coefficients of Normal Breast Fibroglandular Tissue at 3 T. American Journal of Roentgenology 2014, 202 (5), W496-W502.
12. Boss, M. A.; Malyarenko, D.; Partridge, S.; Obuchowski, N.; Shukla-Dave, A.; Winfield, J. M.; Fuller, C. D.; Miller, K.; Mishra, V.; Ohliger, M.; Wilmes, L. J.; Attariwala, R.; Andrews, T.; deSouza, N. M.; Margolis, D. J.; Chenevert, T. L., The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker. Radiology 2024, 313 (1), e233055.